Track market-moving stories before they get noisy

, /PRNewswire/ -- GIPHY, the world's leading platform for visual self-expression, today announced a multi-year extension of its long-standing integration partnership with Meta. Through this agreement, GIPHY's massive library will continue to power GIF and sticker experiences across Meta's entire suite of apps, including Facebook, Instagram, WhatsApp, and Messenger.

GIFs and stickers have become a core part of how people communicate. Across Meta platforms, GIFs and stickers are shared daily, underscoring the role of visual expression in everyday conversations. This partnership reinforces GIPHY's role in enabling dynamic communication at scale across the apps people use every day.

"People don't always want to type how they feel. They want to show it," said Kevin Hein, Chief Growth Officer at GIPHY. "GIPHY makes that possible across Meta's apps every day. This ongoing partnership ensures that experience stays seamless as communication continues to evolve."

GIPHY's library of GIFs, stickers, and short-form content is embedded directly into user experiences, enabling people to express emotion and intent without leaving the apps they're already using. The renewed partnership reflects a shared focus on making digital communication more visual, immediate, and intuitive.

GIPHY recently commissioned a consumer survey by Censuswide that shows users feel more comfortable expressing emotions through visuals than texts. With GIPHY's integration across Meta apps people can take their communication beyond what text and standard emojis can convey.

GIPHY is a wholly-owned subsidiary of Shutterstock, Inc. (NYSE: SSTK), a family of brands delivering scalable creative and GenAI solutions to help customers fuel great work.

ABOUT GIPHY
Founded in 2013, GIPHY Inc. is the visual communication platform where thousands of creators, media, and brand partners make everyday expression a little more moving. GIPHY empowers you to discover and share the GIFs, Clips, and Stickers that make your conversations more positive, more expressive, and more you. In addition, GIPHY Ads enables brands to connect with their audiences through ads people share, not just see. Acquired by Shutterstock in 2023, GIPHY's platform has a daily user reach of 1+ billion to which it serves 10+ billion pieces of short-form content every day. For more information, visitGIPHY.com or follow us on Instagram, Twitter, Facebook, and TikTok @GIPHY.

ABOUT SHUTTERSTOCK, INC.
Shutterstock is in the business of turning ideas into impact. Powered by a global network of millions of creators and our cutting-edge technology, we provide businesses, creatives, and brand leaders with the essential, universal ingredients to make their work more effective. Shutterstock offers access to one of the world's largest and most diverse collections of high-quality licensable assets, specialized training datasets, evaluation tools, and end-to-end strategic partnerships for the full model training lifecycle, as well as advertising and distribution solutions, exclusive editorial content, and full-service studio production—delivering unparalleled resources to fuel great work.

Discover our impact at www.shutterstock.com and connect with us on LinkedIn, Instagram, X, Facebook and YouTube.

View original content to download multimedia:https://www.prnewswire.com/news-releases/giphy-extends-multi-year-integration-partnership-with-meta-302775405.html

SOURCE Shutterstock, Inc.

, /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK), a family of brands delivering scalable creative and GenAI solutions to help customers fuel great work, today unveiled the next evolution of its content library into a human-led, AI-powered creative platform. The advanced creative system combines premium human-made content, AI-powered creation tools, and intuitive workflows to help creatives move from idea to impact without starting from scratch.

Built for real people and real-world creative work, Shutterstock’s AI-powered creative platform combines premium human-made content with AI tools to help creators move from idea to impact without starting from scratch. As businesses and creators adopt AI, many are looking for ways to move faster without sacrificing authenticity, creative control, or commercial confidence. Shutterstock's platform is designed to address that challenge. Starting with Shutterstock's global library of authentic, licensable content created by real contributors around the world, users can discover, adapt, and refine content with embedded AI capabilities, while contributors continue to earn royalties when their content is edited with AI tools and licensed through the platform. With access to leading generative AI models, customers can transform existing content into commercially ready work, helping turn near-perfect assets into exactly what a project requires.

"In an AI-powered world, real-world customers are solving creative problems," said Paul Teall, Vice President, Marketplace Strategy at Shutterstock. "Our updated platform lets creatives get inspired by premium human-made content and then use integrated AI tools to adapt, refine, and personalize it for their needs. Instead of moving between separate tools and workflows, creators can work more seamlessly from inspiration to final output."

Shutterstock's AI-powered creative platform brings together:

Premium human-made content blended with powerful, inline AI editing capabilities AI-powered image and video generation that helps transform existing assets and ideas into new creative possibilities Proprietary Model Match technology that automatically connects prompts with the AI model best suited to the creative task, taking the guesswork out of model selection Conversational AI search and discovery that helps users find the right content through natural language Deeper integrations with AI-native workflows, including a Shutterstock app available in ChatGPT Workflow features including content reference and first frame reference that help users build from existing assets, maintain visual consistency, and guide AI outputs, as well as prompt enhancement for richer queries Human support teams that provide creative guidance and workflow expertise Commercial-ready licensing and indemnification backed by human review for AI-generated content Shutterstock's platform is built around three core strengths and a simple philosophy: built for real people doing real-world creative work and elevated by AI.

Built for Real, Elevated by AI
The best AI-powered work starts with something real. Shutterstock's platform is built on authentic, premium content created by real contributors around the world, then elevated through AI-powered tools and workflows.

Intuitively Integrated
Search, generate, edit, and refine content within one seamless workflow designed to reduce friction and simplify modern creative production. Tools that understand nuance, intent, and creative context help users create the way they think at every stage of the creative process.

Commercial-Ready
High-quality, licensable assets and AI-assisted outputs built for real campaigns, real brands, and real-world deployment.

"Businesses do not need disconnected AI tools. They need creative systems that work together," said Teall. "By combining trusted content, leading AI models, and human expertise in one platform, Shutterstock helps customers create faster, scale confidently, and produce work that is ready for the real world."

As organizations increasingly integrate AI into creative and marketing workflows, Shutterstock is uniquely positioned to bridge the gap between human creativity and machine intelligence by combining trusted content, intuitive AI, and commercial confidence within one connected ecosystem.

Today's launch reflects Shutterstock's broader evolution into a full-spectrum AI company serving both creative professionals and enterprise AI builders. While Shutterstock's AI-powered creative platform helps marketers, brands, and creators produce commercially ready work faster, Shutterstock's Data Licensing & AI Services business powers the underlying AI ecosystem itself through high-quality training data, model evaluation, and human-in-the-loop expertise for leading technology companies and model developers.

Shutterstock Data Licensing & AI Services 
Shutterstock is an end-to-end AI model training partner that unifies data licensing, services, and long-term collaboration under a single provider—reducing operational complexity and helping teams bring higher-performing AI systems to market faster and with greater confidence. Shutterstock combines access to one of the world's largest rights-cleared multimodal datasets with advanced data curation and custom training datasets to power high-performing, deployment-ready generative models. This licensable training data includes high-quality labeled and continuously updated multimodal content with clear data provenance to support AI compliance. Shutterstock leverages ML-assisted evaluation tools to provide model training, fine-tuning, alignment, evaluation, and retraining. Through human-in-the-loop workflows, expert creative feedback, and structured preference data, Shutterstock delivers aesthetic preference signals, benchmarking, and regression testing to drive continuous model improvement.

Learn more and start the conversation at shutterstock.com/data-licensing.

About Shutterstock
Shutterstock is in the business of turning ideas into impact. Powered by a global network of millions of creators and our cutting-edge technology, we provide businesses, creatives, and brand leaders with the essential, universal ingredients to make their work more effective. Shutterstock offers access to one of the world's largest and most diverse collections of high-quality licensable assets, specialized training datasets, evaluation tools, and end-to-end strategic partnerships for the full model training lifecycle, as well as advertising and distribution solutions, exclusive editorial content, and full-service studio production—delivering unparalleled resources to fuel great work.

Discover our impact at www.shutterstock.com and connect with us on LinkedIn, Instagram, X, Facebook and YouTube.

SOURCE Shutterstock, Inc.

AdviceOne Advisory Services LLC acquired a new stake in shares of Latham Group, Inc. (NASDAQ: SWIM) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 130,186 shares of the company's stock, valued at approximately $991,000. Latham Group comprises approximately 0.7% of

Year-Over-Year Sales Growth Achieved Across All Three Product Lines; Positive Sales Trends Continued in April Sand State Strategy on Track with Double-Digit Sales Growth in Florida Gross Margin Expanded by 220 Basis Points Benefiting from Volume Leverage, Lean Manufacturing and Value Engineering EfficienciesReaffirms Full Year Guidance for 9.0% Net Sales Growth and 12.7% Adjusted EBITDA Growth at the Midpoints First Quarter 2026 Financial Highlights:

Net sales of $117.3 million, up 5.3%Net loss of $8.5 million / Net loss per diluted share of $0.07Adjusted EBITDA of $12.2 million / 10.4% of net sales
LATHAM, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- Latham Group, Inc. (Nasdaq: SWIM), the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand, today announced financial results for the first quarter 2026 ended March 28, 2026.

Commenting on the results, Sean Gadd, President and CEO, said, “We continue to execute effectively on our strategic priorities and achieved sales growth in each of our product lines in the first quarter. Sales growth was led by gains in autocovers and liners and the benefits of the Freedom Pools acquisition, while adverse weather conditions in North America kept organic in-ground pool sales steady year-over-year. Adjusted EBITDA growth outpaced sales growth by a considerable margin, demonstrating Latham’s substantial operating leverage and cost discipline, which more than offset the impact of higher investments in growth initiatives.

“We continued to gain traction in Florida – our initial Sand State target market – where Latham’s fiberglass pool sales increased at a double-digit rate in the first quarter. This growth reflected the new dealer sign-ups we executed in 2025 and increased brand and product awareness driven by our advertising and marketing campaign. To accelerate our growth in Florida and the other Sand State markets, we are moving forward with several new initiatives to capture consumer demand and provide additional value to our dealers. They include the build out of our commercial organization, a new market development framework around segmentation by neighborhood, and the addition of sales resources in the field to keep Latham engaged with the consumer throughout the pool purchasing process while linking customers to our dealer network. These initiatives will be supported by a targeted marketing campaign aimed at educating consumers on the benefits of fiberglass and pool ownership.”

First Quarter 2026 Results Compared to the Prior-Year Period

Net sales increased 5.3% to $117.3 million. The increase in net sales during the quarter was primarily the result of organic growth in covers and liners, the acquisition of Freedom Pools, sales growth in Florida, and the full year benefit of the 2025 price increase partially offset by adverse weather conditions across North America.

  First Quarter Net Sales by Product Line
(in thousands)   Fiscal Quarter Ended March 28, 2026March 29, 2025In-Ground Swimming Pools$59,731$57,734Covers 33,498 31,611Liners 24,086 22,075Total$117,315$111,420
Gross profit increased by 13.0% to $37.2 million. Gross margin expanded by 220 basis points to 31.7%. The increase reflected volume leverage and the benefits of lean manufacturing and value engineering initiatives.

Selling, general, and administrative expenses (“SG&A”) increased by 19.5% to $36.6 million. The increase in SG&A was primarily due to acquisition and integration related costs, increased sales and marketing investment to accelerate the fiberglass conversion strategy in the Sand State markets, and our digital transformation efforts.

Net loss was $8.5 million, or $0.07 per diluted share, compared to $6.0 million, or $0.05 per diluted share, in the prior-year period. Net loss margin was 7.3% compared to 5.4%.

Adjusted EBITDA increased by 9.2% to $12.2 million, and adjusted EBITDA margin expanded by 40 basis points to 10.4%.

Balance Sheet, Cash Flow, and Liquidity

Latham ended the first quarter of 2026 with cash of $27.5 million. Net cash used in operating activities was $47.7 million, representing seasonal working capital requirements in line with the Company’s expectations.

Total debt was $311.2 million at the end of the first quarter, and the net debt leverage ratio was 2.8.

Capital expenditures totaled $22.5 million in the first quarter of 2026, which includes $4.9 million related to ongoing projects and $17.6 million related to the purchase of four key fiberglass production sites – this consisted of a $5.6 million payment and a $12.0 million deposit made in 2025 and settled in the first quarter of 2026. This compares to $3.5 million in capital expenditures in the first quarter of 2025. In addition, the Company completed the purchase of Freedom Pools for a purchase price of $17.0 million.

Summary and Outlook

“Latham continues to be distinguished in the marketplace by our consistent outperformance compared to new U.S. pool starts. This track record is a result of our category leadership position, the quality of our products, our excellent execution, and the commitment of our people – all of which contribute to both our performance and our resilience.

“We are pleased to reaffirm our guidance, which is contained in the table below and represents year-over-year sales growth of 9.0% and adjusted EBITDA growth of 12.7%, at the midpoints, within a U.S. in-ground pool market that is expected to be approximately flat with 2025 levels,” Mr. Gadd concluded.

   FY 2026 Guidance Ranges    LowHighNet Sales$580 million$610 millionAdjusted EBITDA1$105 million$120 millionCapital Expenditures$42 million$48 million 1)   A reconciliation of Latham’s projected Adjusted EBITDA to net income (loss) for 2026 is not available without unreasonable effort due to uncertainty related to our future income tax expense (benefit).

Conference Call Details

Latham will hold a conference call to discuss its first quarter 2026 financial results today, May 5, 2026, at 4:30 PM Eastern Time.

Participants are encouraged to pre-register for the conference call by visiting https://dpregister.com/sreg/10207783/103af06e389. Callers who pre-register will be sent a confirmation e-mail including a conference passcode and unique PIN to gain immediate access to the call. Participants may pre-register at any time, including up to and after the call start time. To ensure you are connected for the full call, please register at least 10 minutes before the start of the call.

A live audio webcast of the conference call, along with related presentation materials, will be available online at https://ir.lathampool.com/ under “Events & Presentations”.

Those without internet access or unable to pre-register may dial in by calling:

PARTICIPANT DIAL IN (TOLL FREE): 1-833-953-2435
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-317-5764

An archived webcast will be available approximately two hours after the conclusion of the call, through May 5, 2027, on the Company’s investor relations website under “Events & Presentations”. A transcript of the event will also be available on the Company’s investor relations website approximately three business days after the call.

About Latham Group, Inc.

Latham Group, Inc., headquartered in Latham, NY, is the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand. Latham has a coast-to-coast operations platform consisting of approximately 1,900 employees on average across around 35 locations.

Non-GAAP Financial Measures

We track our non-GAAP financial measures to monitor and manage our underlying financial performance. This earnings release includes the presentation of Adjusted EBITDA, Adjusted EBITDA margin, net debt and net debt leverage ratio which are non-GAAP financial measures that exclude the impact of certain costs, losses, and gains that are required to be included under U.S. GAAP. Although we believe these measures are useful to investors and analysts for the same reasons it is useful to management, as discussed below, these measures are neither a substitute for, nor superior to, GAAP financial measures or disclosures. Other companies may calculate similarly-titled non-GAAP measures differently, limiting their usefulness as comparative measures. In addition, our presentation of non-GAAP financial measures should not be construed to imply that our future results will be unaffected by any such adjustments. We have reconciled our historic non-GAAP financial measures to the applicable most comparable GAAP measures in this earnings release.

Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA and Adjusted EBITDA margin are key metrics used by management and our board of directors to assess our financial performance. Adjusted EBITDA and Adjusted EBITDA margin are also frequently used by analysts, investors and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures. We use Adjusted EBITDA and Adjusted EBITDA margin to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, to utilize as a significant performance metric in our incentive compensation plans, and to compare our performance against that of other companies using similar measures. We have presented Adjusted EBITDA and Adjusted EBITDA margin solely as supplemental disclosures because we believe they allow for a more complete analysis of results of operations and assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance, such as (i) depreciation and amortization, (ii) interest expense, net, (iii) income tax expense (benefit), (iv) (gain) loss on sale and disposal of property and equipment, (v) restructuring charges, (vi) stock-based compensation expense, (vii) unrealized (gains) losses on foreign currency transactions, (viii) strategic initiative costs, (ix) acquisition and integration related costs and (x) other.

Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP financial measures and should not be considered as alternatives to net income (loss) as a measure of financial performance or any other performance measure derived in accordance with GAAP, and they should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. We encourage you to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA and Adjusted EBITDA margin, you should be mindful that in the future we may incur expenses that are the same as or similar to some of the adjustments in this earnings release. There can be no assurance that we will not modify the presentation of Adjusted EBITDA and Adjusted EBITDA margin in the future, and any such modification may be material. In addition, other companies, including companies in our industry, may not calculate Adjusted EBITDA and Adjusted EBITDA margin at all or may calculate Adjusted EBITDA and Adjusted EBITDA margin differently and accordingly, are not necessarily comparable to similarly entitled measures of other companies, which reduces the usefulness of Adjusted EBITDA and Adjusted EBITDA margin as tools for comparison.

Adjusted EBITDA and Adjusted EBITDA margin have their limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that Adjusted EBITDA and Adjusted EBITDA margin:

do not reflect every expenditure, future requirements for capital expenditures or contractual commitments;do not reflect changes in our working capital needs;do not reflect the interest expense, net, or the amounts necessary to service interest or principal payments, on our outstanding debt;do not reflect income tax (benefit) expense, and because the payment of taxes is part of our operations, tax expense is a necessary element of our costs and ability to operate;do not reflect non-cash stock-based compensation, which will remain a key element of our overall compensation package; anddo not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations. Although depreciation and amortization are eliminated in the calculation of Adjusted EBITDA and Adjusted EBITDA margin, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA and Adjusted EBITDA margin do not reflect any costs of such replacements.

Net Debt and Net Debt Leverage Ratio

Net Debt and Net Debt Leverage Ratio are non-GAAP financial measures used in monitoring and evaluating our overall liquidity, financial flexibility, and leverage. Other companies may calculate similarly titled non-GAAP measures differently, limiting their usefulness as comparative measures. We define Net Debt as total debt less cash and cash equivalents. We define the Net Debt Leverage Ratio as Net Debt divided by last twelve months (“LTM”) of Adjusted EBITDA. We believe this measure is an important indicator of our ability to service our long-term debt obligations. There are material limitations to using Net Debt Leverage Ratio as we may not always be able to use cash to repay debt on a dollar-for-dollar basis.

Forward-Looking Statements

Certain statements in this earnings release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release other than statements of historical fact may constitute forward-looking statements, including statements regarding our future operating results and financial position, our business strategy and plans, business and market trends, our objectives for future operations, macroeconomic and geopolitical conditions, acquisitions and related benefits, the implementation of our cost reduction plans and expected benefits, and the sufficiency of our cash balances, working capital and cash generated from operating, investing, and financing activities for our future liquidity and capital resource needs. These statements involve known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside of our control, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including: potential breaches to our technological infrastructure and information systems; geopolitical instability and market instability caused by such instability, including as a result of the conflict in the Middle East involving Iran, the U.S., Israel and Lebanon; inflationary impacts, including on consumer demand for our products; the impact of trade policies on our global supply chain, the import or export of goods and their related costs, as well as on consumer confidence; natural disasters, public health issues or other catastrophic events; adverse weather conditions impacting our sales, which can lead to significant variability of sales in reporting periods; interruption of our production capability at our manufacturing facilities from accident, fire, calamity and other causes; unfavorable economic conditions and related impact on consumer spending and demand for our products; our ability to keep pace with technological developments and standards, such as generative artificial intelligence; compliance with government regulations; declining home ownership affecting demand for our products; our ability to globally source raw materials and components for manufacturing our products; competitive risks; product quality issues, warranty claims or safety concerns such as those due to the failure of builders to follow our product installation instructions and specifications; our ability and the cost to obtain transportation services; the protection of our intellectual property and defense of third-party infringement claims; international business risks; realizing anticipated benefits from acquisitions; possible asset impairments; and our ability to secure financing and our substantial indebtedness; and other factors set forth under “Risk Factors” and elsewhere in our most recent Annual Report on Form 10-K and subsequent reports we file with the SEC. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time that may impair our business, financial condition, results of operations and cash flows.

Although we believe that the expectations reflected in the forward-looking statements are reasonable and our expectations based on third-party information and projections are from sources that management believes to be reputable, we cannot guarantee future results, levels of activities, performance or achievements. These forward-looking statements reflect our views with respect to future events as of the date hereof or the date specified herein, and we have based these forward-looking statements on our current expectations and projections about future events and trends. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we undertake no obligation to update or review publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date hereof. We anticipate that subsequent events and developments will cause our views to change. Our forward-looking statements further do not reflect the potential impact of any future acquisitions, merger, dispositions, joint ventures or investments we may undertake.

Contact:
Lynn Morgen
Casey Kotary
ADVISIRY Partners
[email protected]
212-750-5800

  Latham Group, Inc.
Condensed Consolidated Statements of Operations
(in thousands, except share and per share data)
(unaudited)     Fiscal Quarter Ended   March 28, 2026 March 29, 2025 Net sales $117,315  $111,420  Cost of sales  80,158   78,539  Gross profit  37,157   32,881  Selling, general, and administrative expense  36,589   30,620  Amortization  7,169   7,192  Loss from operations  (6,601)  (4,931) Other expense:       Interest expense, net  4,756   6,371  Other expense (income), net  818   (308) Total other expense, net  5,574   6,063  Earnings from equity method investment  835   953  Loss before income taxes  (11,340)  (10,041) Income tax benefit  (2,806)  (4,079) Net loss $(8,534) $(5,962) Net loss per share attributable to common stockholders:       Basic $(0.07) $(0.05) Diluted $(0.07) $(0.05) Weighted-average common shares outstanding – basic and diluted       Basic  116,894,080   115,885,111  Diluted  116,894,080   115,885,111        Latham Group, Inc.
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
(unaudited)       March 28, December 31,  2026  2025 Assets      Current assets:      Cash $27,481  $71,043 Trade receivables, net  89,213   39,914 Inventories, net  87,609   74,926 Income tax receivable  15,203   12,178 Prepaid expenses and other current assets  10,367   20,943 Total current assets  229,873   219,004 Property and equipment, net  138,154   118,820 Equity method investment  27,317   26,482 Deferred tax assets  1,056   718 Operating lease right-of-use assets  29,621   30,723 Goodwill  161,144   155,189 Intangible assets, net  265,541   268,073 Other assets  3,699   4,214 Total assets $856,405  $823,223 Liabilities and Stockholders’ Equity      Current liabilities:      Accounts payable $29,874  $19,283 Revolving Credit Facility  31,000   — Current maturities of long-term debt  3,250   3,250 Income tax payable  619   — Current operating lease liabilities  6,792   7,630 Accrued expenses and other current liabilities  50,732   48,979 Total current liabilities  122,267   79,142 Long-term debt, net of discount, debt issuance costs, and current portion  276,983   276,591 Deferred income tax liabilities, net  34,269   34,269 Non-current operating lease liabilities  23,633   23,964 Other long-term liabilities  2,551   3,396 Total liabilities $459,703  $417,362 Commitments and contingencies      Stockholders’ equity:      Preferred stock, $0.0001 par value; 100,000,000 shares authorized as of both March 28, 2026 and December 31, 2025; no shares issued and outstanding as of both March 28, 2026 and December 31, 2025  —   — Common stock, $0.0001 par value; 900,000,000 shares authorized as of March 28, 2026 and December 31, 2025; 117,407,719 and 116,766,927 shares issued and outstanding, as of March 28, 2026 and December 31, 2025, respectively  12   12 Additional paid-in capital  472,145   473,423 Accumulated deficit  (72,226)  (63,692)Accumulated other comprehensive loss  (3,229)  (3,882)Total stockholders’ equity  396,702   405,861 Total liabilities and stockholders’ equity $856,405  $823,223     Latham Group, Inc.
Condensed Consolidated Statements of Cash Flows
(in thousands)
(unaudited)     Fiscal Quarter Ended  March 28, March 29,  2026  2025 Cash flows from operating activities:      Net loss $(8,534) $(5,962)Adjustments to reconcile net loss to net cash used in operating activities:      Depreciation and amortization  13,067   12,400 Gain on insurance proceeds received for capital      Unrealized foreign currency loss (gain)  848   (417)Amortization of deferred financing costs and debt discount  430   430 Non-cash lease expense  1,855   1,776 Change in fair value of interest rate swap  (841)  283 Stock-based compensation expense  1,104   1,971 Bad debt expense  815   875 Other non-cash, net  62   (63)Earnings from equity method investment  (835)  (953)Changes in operating assets and liabilities:      Trade receivables  (49,505)  (52,550)Inventories  (9,630)  (9,559)Prepaid expenses and other current assets  (836)  189 Income tax receivable  (3,025)  (4,624)Other assets  (120)  (10)Accounts payable  9,708   14,271 Accrued expenses and other current liabilities  (2,279)  (4,861)Other long-term liabilities  (4)  (78)Net cash used in operating activities  (47,720)  (46,882)Cash flows from investing activities:      Purchases of property and equipment  (10,500)  (3,452)Acquisition of business, net of cash acquired  (14,399)  (4,934)Net cash used in investing activities  (24,899)  (8,386)Cash flows from financing activities:      Proceeds from borrowings on revolving credit facility  31,000   25,000 Repayments of finance lease obligations  (216)  (201)Common stock withheld for taxes on restricted stock units  (2,382)  (2,306)Net cash provided by financing activities  28,402   22,493 Effect of exchange rate changes on cash  655   343 Net decrease in cash  (43,562)  (32,432)Cash at beginning of period  71,043   56,398 Cash at end of period $27,481  $23,966 Supplemental cash flow information:      Cash paid for interest $5,348  $6,266 Income taxes paid, net  (118)  344 Supplemental disclosure of non-cash investing and financing activities:      Purchases of property and equipment included in accounts payable and accrued expenses $698  $1,360 Right-of-use operating and finance lease assets obtained in exchange for lease liabilities  7,785   994 Purchase of property and equipment through settlement of deposit  12,000   —    Latham Group, Inc.
Adjusted EBITDA and Adjusted EBITDA Margin Reconciliation
(Non-GAAP Reconciliation)
(in thousands)    Fiscal Quarter Ended  March 28, 2026 March 29, 2025        Net loss$(8,534) $(5,962) Depreciation and amortization 13,067   12,400  Interest expense, net 4,756   6,371  Income tax benefit (2,806)  (4,079) Gain on sale and disposal of property and equipment —   (69) Restructuring charges(a) —   15  Stock-based compensation expense(b) 1,104   1,971  Unrealized losses (gains) on foreign currency transactions(c) 997   (417) Strategic initiative costs(d) 450   644  Acquisition and integration related costs(e) 3,126   267  Other(f) —   (2) Adjusted EBITDA$12,160  $11,139  Net sales$117,315  $111,420  Net loss margin (7.3)% (5.4)%Adjusted EBITDA margin 10.4 % 10.0 % (a)  Represents costs that include severance and other expenses for our executive management changes.
(b)  Represents non-cash stock-based compensation expense.
(c)  Represents unrealized foreign currency transaction losses (gains) associated with our international subsidiaries.
(d)  Represents fees paid to external consultants and other expenses for our strategic initiatives.
(e)  Represents acquisition and integration costs, as well as other costs related to potential transactions.
(f)  Other costs consist of other discrete items as determined by management, primarily including: (i) fees paid to external advisors for various matters and (ii) other items.

 Latham Group, Inc.
Net Debt Leverage Ratio
(Non-GAAP Reconciliation)
(in thousands)    March 28, 2026 Total Debt $311,233     Less:   Cash  (27,481)Net Debt  283,752     LTM Adjusted EBITDA(1)  100,852 Net Debt Leverage Ratio  2.81x      (1)  LTM Adjusted EBITDA is defined as Adjusted EBITDA for the most recent 12-month period.

Latham Group, Inc. (SWIM) Q1 2026 Earnings Call Transcript

Latham Group is a compelling value play in the in-ground residential pool market, despite recent share price weakness. SWIM boasts a dominant 50% share in the premium fiberglass pool segment, with recurring replacement revenue streams supporting resilience. Recent acquisition of Freedom Pools and organic growth in key markets, especially Florida, are driving revenue and EBITDA expansion.

The overall crypto market may be reeling, but the stablecoin industry continues to grow at a prodigious rate. Stablecoins are now worth $300 billion and could be worth upwards of $3 trillion by the end of 2030, according to Treasury Secretary Scott Bessent.

So, what's the best way to get exposure to these dollar-pegged digital currencies? The latest Motley Fool research on stablecoins highlights three ways investors can get exposure to the stablecoin boom.

Image source: Getty Images.

Card issuers and payment networks As a starting point, it's worth considering two credit card behemoths: Mastercard (MA 0.67%) and Visa (V 1.27%). Both are now putting their full weight behind new blockchain-based payment initiatives, including some that feature stablecoins.

As the new Motley Fool research points out, Visa and Mastercard are not trying to become stablecoin issuers. Instead, they are positioning themselves as the connective layer between stablecoin wallets and the existing payments infrastructure. As stablecoin payments scale, both Visa and Mastercard are attempting to stay one step ahead of the competition.

With that in mind, Mastercard launched a global Crypto Partner Program in March 2026 with more than 85 digital asset and fintech firms, including PayPal (PYPL 0.91%), Circle Internet Group (CRCL +2.42%), Binance (BNB +0.98%), Gemini (GEMI +2.20%), Kraken, MetaMask, and Ripple. For its part, Visa has begun accepting stablecoin payments through various crypto partners, allowing customers to link their Visa cards to stablecoin wallets.

Today's Change

(

-0.67

%) $

-3.28

Current Price

$

485.80

Banks and financial institutions The Motley Fool research also highlights that a number of top banks and financial institutions are running stablecoin pilot projects. These include JPMorgan Chase (JPM +0.51%), Bank of America (BAC +0.18%), and Citigroup (C +1.28%).

Here's where the lines really begin to blur between traditional finance and blockchain finance. The growing consensus is that stablecoins, running entirely on blockchain payment rails, could make a lot of sense in terms of cost savings and potential efficiencies.

But it's not clear right now what the best strategy is. Should these banks offer their own stablecoins, or should they use popular stablecoins -- such as Tether (USDT 0.04%) or USDC (USDC +0.00%) -- that already exist? Or should they hedge their bets and partner with a large group of banks to offer a new type of dollar-pegged stablecoin with its own unique properties?

Stablecoin issuers The final option -- and arguably the riskiest -- is to invest in stablecoin issuers such as Circle Internet Group. As the issuer of the $77 billion USDC stablecoin, Circle is the best pure-play stablecoin investment opportunity. By investing in Circle stock, it's possible to get direct exposure to the high-flying stablecoin trend.

What's interesting here is that a number of top fintech firms are also throwing their hats into the stablecoin ring. These include PayPal, which issued a stablecoin in 2023, as well as Ripple, the company behind the XRP (XRP 0.47%) token, which issued a stablecoin in 2024. The market cap of PayPal USD (PYUSD +0.00%) is currently $3.5 billion, while the market cap of Ripple USD (RLUSD +0.00%) is $1.5 billion.

If you're really willing to take a flier, you could choose to invest in highly speculative cryptocurrencies such as Stable (STABLE 1.31%) that offer direct exposure to stablecoins. Stable, with a market cap of $725 million, has emerged as the first Layer 1 blockchain dedicated entirely to stablecoins. The goal is to create a thriving blockchain ecosystem around the $190 billion Tether stablecoin.

Caveats for investors Just remember -- it's still early innings for stablecoins. While top card issuers, payment networks, and banks are experimenting with stablecoins, these dollar-pegged digital currencies still do not make a meaningful impact on either the top line or the bottom line of these behemoth companies.

Moreover, as the Motley Fool stablecoin research points out, a key factor to keep in mind is the overall regulatory and legal environment for stablecoins. The pending Digital Asset Market Clarity Act (Clarity Act) could have a huge impact on not just which stablecoins soar in popularity but also how easy it is for banks and fintech firms to integrate them into their global payment infrastructure.

Right now, I'm focused on Circle as the best way to play the stablecoin boom. But I'm also keeping my eye on what Mastercard is doing. Its sprawling Crypto Partner Program is sure to produce some new winners, and that's where things could really get interesting.

JPMorgan Chase is an advertising partner of Motley Fool Money. Bank of America is an advertising partner of Motley Fool Money. Citigroup is an advertising partner of Motley Fool Money. Dominic Basulto has positions in Circle Internet Group, PayPal USD, USDC, and XRP. The Motley Fool has positions in and recommends JPMorgan Chase, Mastercard, PayPal, Visa, and XRP. The Motley Fool recommends BNB and recommends the following options: short June 2026 $50 calls on PayPal. The Motley Fool has a disclosure policy.

Circle Internet Group, Inc. (NYSE: CRCL) announced today that Jeremy Allaire, Co-Founder, Chairman and Chief Executive Officer, will participate in a fireside chat at the Bernstein 42nd Annual Strategic Decisions Conference on Thursday, May 28, 2026 at 8:00am ET.

The live audio webcast of the session will be available on Circle’s Investor Relations website at www.circle.com/investors. For those unable to listen to the live webcast, a replay will be available on our website shortly after the event.

Please direct any questions regarding obtaining access to the webcast to Circle Investor Relations via email at [email protected].

Disclosure Information

In addition to filings with the Securities and Exchange Commission (SEC), Circle uses its Investor Relations website (https://investor.circle.com), its blog (https://www.circle.com/blog), press releases (https://www.circle.com/pressroom), public conference calls and webcasts, its X feed (https://x.com/circle), and its Linkedin page (https://www.linkedin.com/company/circle-internet-financial) as a means of disclosing material nonpublic information, announcing upcoming investor conferences and for complying with its disclosure obligations under Regulation FD. Accordingly, investors should monitor these sites in addition to following Circle’s SEC filings.

About Circle Internet Group, Inc.

Circle (NYSE: CRCL) is one of the world’s leading internet financial platform companies, building the foundation of a more open, global economy through programmable blockchain infrastructure, digital assets, and payment applications. Circle’s platform includes the world’s largest stablecoin network anchored by USDC, Circle Payments Network for global money movement, and Arc, an enterprise-grade blockchain designed to become the Economic OS for the internet. Enterprises, financial institutions, and developers use Circle to power trusted, internet-scale financial innovation.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260521423159/en/

The next phase of crypto's public-market pitch is less about token prices and more about financial infrastructure. As trading revenue slows, companies including Coinbase, Robinhood, Circle, Bullish and Gemini are trying to show they can own the systems that issue, trade, settle and record assets.

The partnership brings USDC-powered settlement together with Nium's last-mile global payouts across more than 190 countries, enabling stablecoin payments for global businesses.

, /PRNewswire/ -- Nium, the global leader in real-time cross-border payments infrastructure, and Circle Technology Services, LLC, an affiliate of Circle Internet Group, Inc. (NYSE: CRCL) ('Circle') and operator of Circle Payments Network (CPN), today announced a partnership to connect stablecoin settlement with last-mile global payouts.

As part of the partnership, Nium joins CPN as a global payout partner, providing financial institutions on the network with direct access to Nium's payout infrastructure across more than 190 countries and in 100 currencies.

Nium x Circle Partnership (PRNewsfoto/Nium) With Nium now part of CPN, financial institutions can route payments through the CPN network to Nium's payout infrastructure, including access to Nium's entire portfolio of countries and currencies through a single integration. Payments using CPN will now be supported by integrated FX optimization and smart routing, enabling efficient conversion and delivery without the need to source and manage multiple local providers.

Together, Circle and Nium provide a unified foundation for global payments. Circle delivers regulated, USDC[1]-powered settlements with built-in compliance and a governed network designed for institutional use. Nium enables local currency delivery through real-time, last-mile payout rails and extensive regulatory coverage, allowing institutions to deliver funds delivered in local currency into accounts, wallets, and cards worldwide.

This partnership addresses a key challenge in cross-border payments: bridging fast, transparent settlements with reliable last-mile delivery. By joining CPN, Nium enables institutions to access capabilities through a single payment network without managing fragmented providers and prefunding accounts across multiple corridors.

"Traditional and onchain payment rails are converging, and that convergence demands infrastructure that banks, fintechs, and global enterprises can rely on at scale," said Prajit Nanu, Founder and CEO of Nium." By partnering with Circle and joining CPN, we are combining Circle's regulated settlement instrument with Nium's global payout reach to deliver a more seamless way for institutions to move money worldwide."

"Financial institutions are increasingly looking for ways to use stablecoins to solve persistent payments pain points," said Kash Razzaghi, Chief Commercial Officer at Circle. "Through our partnership with Nium and their integration into Circle Payments Network, we are extending USDC from a settlement instrument into a complete payments flow, helping institutions move money globally with greater speed, transparency, and capital efficiency."

Circle continues to scale CPN, with $8.3 billion in annualized transaction volume based on the trailing 30day activity as of March 31, 2026[2], reflecting growing institutional adoption of USDC for global payments.

With Nium now part of CPN, financial institutions can:

Move money globally using USDC and enable final settlement through Nium's real-time payout network, enabling faster end-to-end payment flows Reduce prefunding requirements across corridors Access global payout capabilities through a single integration Track transactions in real time with onchain transparency For more information, visit  circle.com/cpn or nium.com.

About Nium
Nium provides global infrastructure for real-time cross-border payments, founded on the mission to deliver the global money movement infrastructure of tomorrow, today. Its platform incorporates the most advanced fiat and blockchain capabilities, enabling banks, fintechs, and enterprises to collect, convert, send, and spend funds instantly across borders. Its payout network supports stablecoins, 100 currencies and spans 190+ countries, over 100 of which are in real-time. Funds can be disbursed to accounts, wallets, and cards, and collected locally in 40 markets.

As a principal card issuer on Visa, Mastercard, Discover, and UATP, Nium issues over 38 million card tokens every year. It holds regulatory licenses and authorizations in more than 40 countries, enabling seamless onboarding, rapid integration, and compliance, independent of geography. Nium is backed by leading investors including Visa, Riverwood Capital, Tribe Capital, and New View Capital. The company is co-headquartered in San Francisco and Singapore. For more information, visit www.nium.com.

About Circle Payments Network
Circle Technology Services, LLC (CTS) is the operator of Circle Payments Network (CPN) and offers products and services to financial institutions that participate in CPN to facilitate their CPN access and integration. CPN connects participating financial institutions around the world, with CTS serving as the technology service provider to participating financial institutions. While CTS does not hold funds or manage accounts on behalf of customers, we enable the global ecosystem of participating financial institutions to connect directly with each other, communicate securely, and settle directly with each other. CTS is not a party to transactions between participating financial institutions facilitated by CPN who use CPN to execute transactions at their own risk. Use of CPN is subject to the CPN Rules and the CPN Participation Agreement between CTS and a participating financial institution. 

[1] USDC is issued by regulated affiliates of Circle. See Circle's list of regulatory authorizations at circle.com/legal/licenses.

[2] Company data as of March 31, 2026.

Photo - https://mma.prnewswire.com/media/2987692/Nium_Circle.jpg
Logo - https://mma.prnewswire.com/media/2333904/5987369/Nium_Logo.jpg

SOURCE Nium

 | 

Nium and Circle have teamed to link stablecoin settlement with global payout infrastructure.

The partnership will see the cross-border payments company join Circle’s Payments Network (CPN) as a payout partner, the companies said in a Thursday (May 27) news release.

This will allow financial institutions to move funds via Circle’s USDC stablecoin and settle in local currencies across more than 190 countries.

“Traditional and onchain payment rails are converging, and that convergence demands infrastructure that banks, fintechs, and global enterprises can rely on at scale,” said Prajit Nanu, founder and CEO of Nium.

“By partnering with Circle and joining CPN, we are combining Circle’s regulated settlement instrument with Nium’s global payout reach to deliver a more seamless way for institutions to move money worldwide.”

The integration provides CPN participants with direct access to Nium’s payout rails through a single interface, supporting transactions in 100 different currencies. This technical connection is designed to streamline the conversion process through integrated foreign exchange (FX) optimization and smart routing.

Advertisement: Scroll to Continue

By automating these steps, the release added, the companies hope to remove the need for institutions to do things like managing multiple local service providers.

“Financial institutions are increasingly looking for ways to use stablecoins to solve persistent payments pain points,” said Kash Razzaghi, chief commercial officer at Circle.

“Through our partnership with Nium and their integration into Circle Payments Network, we are extending USDC from a settlement instrument into a complete payments flow, helping institutions move money globally with greater speed, transparency, and capital efficiency.”

In related news, PYMNTS wrote last week about the use of stablecoins in B2B marketplaces, arguing that the figure of this practice might depend less on technological efficiency and more on whether they preserve the credibility, legal certainty and interoperability that took traditional settlement systems decades to develop.

“Large marketplaces increasingly orchestrate not only transactions but also treasury functions, supplier payments, financing relationships and liquidity management,” the report said. “In many cases, marketplaces already resemble quasi-financial institutions.”

They hold balances, handle payouts, optimize working capital and facilitate international commerce between participants doing business across multiple jurisdictions. However, most of this activity relies on settlement rails created decades ago.

Stablecoins have the potential to compress treasury management, liquidity coordination and payment orchestration into software infrastructure, which could mean faster settlement, automated payouts, and less foreign exchange friction, PYMNTS wrote.

“Yet the more stablecoins position themselves as infrastructure, the more they encounter the same constraints that govern all critical financial infrastructure: trust, legal certainty and settlement finality,” that report added.

Circle (CRCL) is upgraded to Buy as distribution bottleneck risks fade and operating evidence improves. USDC circulation, Circle-controlled balances, and RLDC margins are all showing healthy growth despite lower reserve yields and persistent Coinbase drag. Valuation has compressed to ~8x forward revenue, offsetting slower growth expectations and enhancing risk/reward.

Vancouver, British Columbia--(Newsfile Corp. - June 1, 2026) - Corcel Exploration Inc. (CSE: CRCL) (OTCQB: CRLEF) (the "Company" or "Corcel") is pleased to announce assay results from the first drill hole of the recently completed, Phase 1 drill program at the Yuma King Project (the "Project") located in west-central Arizona.

Drill hole YK26-001 intersected a strong zone of near-surface, skarn-hosted, copper-gold-silver-molybdenum mineralization highlighted by 56.65 meters of 1.07% copper, 0.79 g/t gold, 7.1 g/t silver and 180 ppm molybdenum from 3.35 meters downhole. This drill hole expands on historical drill results and demonstrates the significant mineralization potential of the Yuma King mine area.

Highlights

Significant mineralization in first drill hole: A broad zone of near-surface copper-gold-silver mineralization punctuated with high-grade intervals was intersected in the first drill hole (YK26-001) at the Yuma King mine target. Results include:

56.65 meters of 1.07% Cu, 0.79 g/t Au, 7.1 g/t Ag, and 180 ppm Mo1 starting at 3.35 meters downhole, including,

7.85 meters of 2.28% Cu, 1.14 g/t Au, 6.8 g/t Ag, and 266 ppm Mo from 24 meters downhole and including,

8.80 meters of 2.07% Cu, 1.85 g/t Au, 20.5 g/t Ag, and 312 ppm Mo from 45 meters downhole

Results support current exploration model: Drill results from YK26-001 confirm and expand on historical drill results (e.g., 45.4 meters of 0.78% Cu, 0.53 g/t Au, and 6.3 g/t Ag in drill hole, see news release dated October 7, 2025)1 and demonstrate the significant high-grade and bulk-tonnage mineralization potential of the Yuma King mine target.

Results pending from five additional drill holes: The Phase I drill program consisted of over 1,087 meters across six drill holes and tested over 500 meters of mineralization strike-length. Results are pending from the remaining five drill holes (Figures 1 and 2).

"These are significant initial drill results from our Phase 1 drill program, building on the strong historical drilling completed in 2006 and further supporting the potential for a large-scale, near-surface copper-gold system at Yuma King," commented Jon Ward. "Importantly, this confirmation hole returned higher grades than the historical intercepts."

"The successful completion of our Phase 1 drill program marks an important milestone for the Company, and we look forward to the assay results from the other five drill holes."

Completed Phase I Drill Program

The Phase I drill program at the Yuma King project, near Salome, Arizona, consisted of 1,087 meters across six drill holes (Figure 1, Table 2). Drilling is now complete, with two holes currently at the lab, one drill hole ready for shipment and the final two drill holes undergoing logging and sampling prior to delivery. These drill holes were designed to test over 500 meters of strike-length and the down-dip potential of high-grade skarn-related copper-gold-silver mineralization below historical mine workings (Figure 1). Results from the remaining drill holes will be released once assay data are received, compiled, and interpreted.

Drill hole YK26-001 was designed to evaluate historical drill results from a drill program completed in 2006 by Big Bar Gold. The hole was drilled to the north at a dip of -50o. Based on modeling and review of historical results YK26-001 was planned to expand the mineralization to the north from historical hole YK01-A (Figures 1 and 2). YK26-001 returned a broad zone of near-surface copper-gold-silver mineralization (e.g., 56.65 meters of 1.07% Cu, 0.79 g/t Au, and 7.1 g/t Ag1, Table 1). Mineralization across this zone consists of copper oxides (azurite, malachite, chrysocolla, and tenorite, Figure 3) hosted in copper skarn/replacement in the Redwall Limestone. Results from drill hole YK26-001 confirm and expand on historical drill results and demonstrate the high-grade and bulk-tonnage mineralization potential of the Yuma King target.

Figure 1. Map showing the collar location of drill hole YK26-001 in relation to all recently completed holes with pending results and all historical drill holes. Location of historical underground workings is shown projected to surface.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8415/299607_corcelimg1.jpg

Figure 2. Long section showing the down-hole assay results from drill hole YK26-001 and the results from historical drill holes. Traces of drill holes with pending results are also shown.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8415/299607_corcelimg2.jpg

Figure 3. Photos of drill core from hole YK26-001(50.5 to 53.9 m) showing zones of strong copper oxide mineralization with copper grades annotated.

To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/8415/299607_53b570aa74aada7f_003full.jpg

Table 1. Assay results from drill hole YK26-001

DrillholeIntercept From - To (m)Intercept Thickness1 (m)Cu (%)Au (g/t)Ag (g/t)Mo (ppm)YK26-0013.356056.651.070.797.1180including2431.857.852.281.146.8266including4553.88.802.071.8520.5312Intercepts are drilled widths, true widths are unknown and reported intercepts may not reflect true widths. Table 2. Collar information for drill hole YK26-001

DrillholeEastingNorthingElevationAzimuthDipTotal DepthYK26-0012455243747879640.77341-5091.74YK26-0022455673747870650.3846-50152.4YK26-0032451813747932609.422-60103.3YK26-0042455963747960690.35258-7092.96YK26-0052456473747967691.33180-55127.41YK26-005A2456473747967691.33180-55245.36YK26-0062456943747893700.4250-50274.32Sampling, Quality Assurance/Quality Control (QA/QC)

All sampling was conducted under the supervision of Corcel's geologists, and all drill core analytical results have been monitored through the Company's quality assurance and quality control program (QA/QC). The drill core was sawn in half at Corcel's dedicated and secure core logging and processing facility near Parker, Arizona.

Half of the drill core was sampled and shipped by a bonded courier in sealed and secured woven polyester bags to Agat Laboratories in Calgary, Alberta. Core samples were prepared using standard preparation procedures 200-078 and 200-087 which involve crushing the sample to 80% less than 2mm, followed by a riffle split of 250g, and then a pulverised split to better than 85%, passing 75 microns.

Following sample preparation, the pulps were sent to the Agat Laboratories in Calgary, Alberta for analysis. Agat is registered to ISO/IEC 17025:2017 accreditations for laboratory procedures.

Drill core samples were analyzed for 48 elements, including Cu, Ag, Mo by ICP-OES/MS on a 0.2-gram aliquot using a four-acid digestion (method 201-071 and 201-470 for over-limit results). Gold was analyzed by fire assay on a 50-gram aliquot with an AAS (Atomic Absorption Spectroscopy) finish (method 202-551).

In addition to Agat Laboratories QA/QC protocols, Corcel implements a rigorous internal QA/QC program that includes the insertion of field and lab duplicates, certified reference materials (standards prepared by an independent lab) and blanks into the sample stream. Data verification of the analytical results includes a statistical analysis of the standards and blanks that must pass certain parameters for acceptance to ensure accurate and verifiable results, and the procedures and results are considered acceptable.

Technical Disclosure

Roy Greig, Ph.D., P.Geo, a Qualified Person as defined in National Instrument 43-101 Standards of Disclosure for Mineral Projects, and advisor to Corcel Exploration Inc. has reviewed and approved the technical content in this news release.

About Corcel Exploration Inc.

Corcel Exploration is a mineral resource company engaged in the acquisition and exploration of precious and base metals properties throughout North America. The Company has entered a long-term lease agreement to acquire the Yuma King Cu-Au project in Arizona, which spans a district-scale land position of 3,200 hectares comprising 515 unpatented federal mining claims in the Ellsworth Mining District, including the past-producing Yuma King Mine which saw underground production of copper, lead, gold and silver between 1940 and 1963. For more information, please visit our website at https://corcelexploration.com/.

Caution Regarding Forward-Looking Information

This news release contains "forward-looking information" and "forward-looking statements" within the meaning of applicable Canadian securities laws (collectively, "forward-looking information"). Forward-looking information in this news release includes, without limitation, statements with respect to: the expected receipt, compilation, and interpretation of additional assay results from the remaining five drill holes of the Phase 1 drill program at the Project; the potential for the expansion of known copper-gold-silver mineralized zones at the Yuma King mine target; the potential for the Project to host large-scale, near-surface copper-gold mineralization; the Company's plans to conduct future drilling and other exploration work at the Project, including any Phase II drill program; the anticipated timing, scope, and objectives of such work; the ability to secure permits, approvals, community support and financing on acceptable terms; and the potential for the Project to host an economic mining operation in the future.

Forward-looking information is based on a number of assumptions that, while considered reasonable by the Company at the date of this news release, are inherently subject to significant business, economic, competitive, operational and regulatory uncertainties and contingencies. These assumptions include, without limitation: future commodity prices and exchange rates; availability of financing on reasonable terms; availability of equipment, personnel and infrastructure; maintenance of title and access to properties; obtaining all required regulatory, surface and community approvals on expected terms and within expected timelines; accuracy of current technical information; and the absence of material adverse changes in applicable laws, political conditions, taxation, or capital markets.

Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those expressed or implied. Such risks include, without limitation: commodity price volatility; exploration, development, metallurgical and geological risk; permitting, environmental and regulatory risk; title and access risk; financing and liquidity risk; reliance on contractors and third parties; community, ESG and social license risk; political and security risk in foreign jurisdictions; operational disruptions, accidents and labour matters; changes in laws and taxation; dilution and capital markets risk; and the other risks more fully described under "Risk Factors" in the Company's continuous disclosure filings available under its profile at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information except in accordance with applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/299607

Source: Corcel Exploration Inc.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

If you're coming out of this weekend a little lighter than you were following Thursday's close, you're not alone. The major market indexes took a big hit on Friday, and that didn't tell the full story. A whopping 8% of U.S. exchange-listed stocks posted double-digit percentage declines on the last trading day of the week.

Many might not bounce back right away, but I think Advanced Micro Devices (AMD +1.45%), Groupon (GRPN 0.19%), and Circle Internet Group (CRCL +2.42%) can recover as soon as this week. Let's take a look at Friday's 11% losses across all three, and dig into why they could be buying opportunities here.

Image source: Getty Images.

1. Advanced Micro Devices It was tough to see AMD stock take an 11% hit on Friday, but zoom out and the carnage isn't as bad. AMD has still more than doubled in 2026. The shares have nearly quadrupled over the past year.

Its rapid ascent over the past year isn't a surprise. AMD's central processing units and graphics processing units are moving as the AI revolution intensifies. Keeping up with the booming demand has lit a fire of accelerating growth under AMD's heels. It has posted five consecutive quarters of at least 30% top-line growth. The 38% increase it delivered in its latest quarter is its strongest year-over-year jump in nearly four years.

Today's Change

(

1.45

%) $

6.55

Current Price

$

458.95

The downside to a stock that's up 293% over the past year is that it's harder to make the same valuation argument. AMD has started to pick up the pace on both ends of the income statement in recent quarters, but the stock has fared substantially better. AMD is now trading for 63 times forward earnings, but a more reasonable multiple of 37 based on next year's analyst profit target.

AMD is pressing down on the accelerator even after Friday's bullish sentiment reversal. If 38% is its strongest revenue growth since the second quarter of 2022 -- and that is encouraging -- AMD is expected to grow its business by 43% this year and 57% in 2027. U.S. chip stocks lost a collective $1.3 trillion in market cap on Friday. AMD accounted for 6% of that pain, but that hit can be short-lived if AI demand is still growing.

Today's Change

(

-0.19

%) $

-0.03

Current Price

$

16.06

2. Groupon After eight consecutive years of declining revenue, Groupon bounced back with a marginal uptick in 2025. Reported losses continue, but the provider of deeply discounted local experiences returned to profitability on an adjusted basis in 2025.

Unlike AMD, which has had a great past 12 months, Groupon's stock has shed nearly half of its value over the past year. To be fair, Groupon had almost tripled through the first six months of last year.

The bullish Groupon argument is still there for the making. It's trading at less than 20 times next year's earnings, much cheaper than the two other stocks on this list. Groupon is turning the corner. Revenue is expected to accelerate gradually this year and again in 2027. There's also the business model. Any consumer-facing business is vulnerable to a potential slowdown, but Groupon's platform should benefit from businesses hungry to generate cost-effective leads in a challenging climate. Groupon is built for an audience looking to get more bang for its buck.

Today's Change

(

2.42

%) $

1.91

Current Price

$

80.84

3. Circle Internet Group It wasn't just chip stocks that were hit on Friday. Cryptocurrencies and related investments also took a bearish uppercut. It's easy to see why crypto mining companies and digital currency marketplaces would slide when traders are selling. Circle Internet Group stock should be holding up better.

Circle is a leading issuer of stablecoin products. It also provides blockchain solutions for the cryptocurrency market, but let's go back to its biggest business. Circle is the issuer of USD Coin (USDC +0.00%), a popular stablecoin with a circulation of roughly $75 billion. Circle teamed up with Coinbase (COIN 0.78%) on USD Coin, a currency designed to remain as close as possible to the U.S. dollar (hence the stablecoin designation).

Crypto took a hit last week. USD Coin is still at $1.00. Circle is at the mercy of the more volatile crypto market, not just for its blockchain solutions. If folks cool on crypto, the stablecoin market should also suffer. However, it bears pointing out that analysts see Coinbase revenue sliding 14% this year. Those same Wall Street pros see Circle's top line rising 12% this year, accelerating to a 40% jump come 2027. Opportunity is knocking on all three of these stocks.

On June 6, the Securities and Exchange Commission (SEC) published its Draft Strategic Plan for 2026 to 2030. SEC chairman Paul Atkins, who was sworn in last April, described the draft as the start of a "new day" for clearer crypto regulations, reduced enforcement overreach, and the modernization of the agency's systems to support innovation while protecting investors.

The SEC's focus on the crypto market is one of the most consequential parts of that plan. It states that "crypto asset technologies have the potential to revolutionize America's financial infrastructure and deliver new optionality, efficiencies, cost reductions, transparency, and risk mitigation for the benefit of all Americans."

Image source: Getty Images.

But to nurture its growth, the plan calls for the agency to provide a "firm regulatory foundation for digital assets and distributed ledger technologies through a rational, coherent, and principled approach." It also calls for clearer separation of regulatory responsibilities between the SEC and the Commodity Futures Trading Commission (CFTC) regarding cryptocurrencies.

This draft plan, along with the proposed CLARITY Act to regulate digital assets, indicates that the government is taking cryptocurrencies much more seriously. Let's see which tokens will benefit from that shift -- and which ones could be left in the dust.

The cryptocurrencies that will benefit from tighter regulations The SEC and CFTC have already jointly approved Bitcoin (BTC +0.45%) and Ethereum (ETH 0.32%), the two largest cryptocurrencies, as commodities rather than securities. That designation should shield them from tighter regulations, which will likely classify many smaller cryptocurrencies as "unlicensed securities" rather than commodities.

Today's Change

(

0.45

%) $

278.87

Current Price

$

62435.00

That downward pressure on the smaller tokens should drive more institutional investors to Bitcoin and Ethereum. Ethereum, the world's largest developer-oriented blockchain, will also benefit from a crackdown on smaller decentralized finance (DeFi) and smart contract platforms. Ethereum's more resilient Layer-1 (L1) blockchain competitors, including Solana (SOL +0.70%) and Cardano (SOL +0.70%), should also resist that selling pressure.

Under those new regulations, stablecoins that are fully backed by U.S. dollars and Treasuries could also become a viable alternative to real U.S. dollars. That's bad news for traditional banks, but it's great news for stablecoin issuers like Circle (CRCL +2.42%).

Niche tokens like LINK (LINK 0.15%) and XRP (XRP 0.47%) could also stabilize -- but not necessarily soar -- as the SEC tightens its regulations. LINK will thrive as more developer-driven blockchains draw more data from Chainlink's oracle network (which aggregates real-time data for decentralized apps). XRP, primarily used as a bridge currency for fiat transactions, could gain more momentum as a cheaper, faster alternative to SWIFT for cross-border payments.

The cryptocurrencies that will crumble under tighter regulations Smaller altcoins that aren't valued by their scarcity, like Bitcoin, or by their usefulness to developers, like Ethereum, will likely struggle to attract investors as regulations tighten. The obvious losers include meme coins like Dogecoin and Shiba Inu, which both lost more than half their value over the past 12 months.

Today's Change

(

0.55

%) $

0.00

Current Price

$

0.08

"Privacy coins" like Monero and Dash, which claim to be completely anonymous, could also be delisted under the SEC's new rules. Higher regulatory and compliance costs could also make it much more difficult for small teams of developers to launch new tokens, further consolidating the market under the larger blue chip tokens.

What could the SEC's proposed plans mean for investors? The SEC says the "rapid growth" of the cryptocurrency market has "outpaced the existing regulatory framework". In other words, the crypto market's "wild west" days are ending -- and investors should sell the weaker altcoins that won't survive the tighter market regulations.

They should still stick with the market's bellwethers, like Bitcoin and Ethereum, but they shouldn't expect those top cryptocurrencies to replicate their massive gains from the past decade. Instead, their prices will likely stabilize as they're more broadly used for mainstream payments and financial transactions.

Platform Enhances Support for Businesses Looking to Fund, Manage, and Pay Out Using Stablecoin Infrastructure - Powered by CPN Managed Payments

, /PRNewswire/ -- MassPay, a global payouts platform that enables businesses to pay anyone, anywhere through a single integration, today announced an expanded offering through Circle Payments Network (CPN) Managed Payments, provided by Circle Internet Financial, LLC., an affiliate of Circle Internet Group (NYSE:CRCL).

Building on its existing integration with CPN, MassPay now leverages CPN Management Payments for stablecoin-enabled settlement. The integration enables MassPay customers to fund, manage, and send payouts using stablecoins, without directly managing digital assets or blockchain infrastructure.

CPN Managed Payments is a fully managed settlement solution that enables payment service providers (PSPs), fintechs, banks and global enterprises to access the speed and efficiency of digital dollar-based settlement without holding or managing digital assets directly. It addresses key barriers to adoption by abstracting the complexity associated with digital asset management, enabling institutions to access these capabilities while continuing to operate within familiar financial and compliance frameworks.

This expanded integration strengthens MassPay's ability to support businesses using stablecoins as part of their treasury or payout workflows. MassPay customers can now programmatically create and manage dedicated wallets, convert balances  into USDC for treasury purposes, and initiate stablecoin payouts alongside existing options like bank transfers, debit cards, and digital wallets.

"The way businesses hold and move money is changing," said Ran Grushkowsky, CEO of MassPay. "More and more of our customers are holding stablecoins as a core part of how they manage their finances - not as an experiment, but as an everyday tool.  By leveraging CPN Managed Payments, we can better support our customers holistically - from how they fund their accounts, to how they pay their people and partners, worldwide."

"MassPay's expanded use of Circle Payments Network Managed Payments shows payments companies are looking to bring faster, cheaper, and programmable money movement into their core payout operations," said Irfan Ganchi, SVP of Product Management, Payments at Circle. "By leveraging managed infrastructure through CPN, MassPay enables customers to access stablecoin-powered workflows without directly managing digital assets."

For businesses managing large, global payout operations, this integration supports more efficient cross-border payment workflows, particularly across corridors where traditional settlement processes can be slow or expensive. Stablecoin-enabled settlements can help reduce reliance on multiple intermediaries while improving the speed and predictability of payout operations. MassPay supports a broad range of payout methods - including bank transfers, debit cards, digital wallets, and stablecoin-native payouts - through a single integration. As stablecoins become a more standard part of how global businesses manage money, MassPay is positioned to support that shift with CPN Managed Payments. .

About MassPay

We care about your people getting paid, anywhere. MassPay is a leading global payout orchestration platform empowering businesses to move money instantly, compliantly, anywhere, at scale. With a single, easy-to-integrate API, MassPay enables businesses to make real-time payouts to payees via bank transfers, digital wallets, debit cards, cryptocurrency, or cash pickup. The platform combines instant settlement capabilities with embedded compliance and KYC features, ensuring a secure payout experience for marketplaces, direct sales organizations, content creator platforms, and any business that requires a reliable, scalable global payout solution. Learn more at masspay.io.

MEDIA CONTACT:
C-Suite Media Strategies
Kristopher Conesa
[email protected]
www.csuitepr.com
305-975-5934

SOURCE MassPay

Cadence Design Systems (CDNS - Free Report) came out with quarterly earnings of $1.96 per share, beating the Zacks Consensus Estimate of $1.88 per share. This compares to earnings of $1.57 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +4.26%. A quarter ago, it was expected that this maker of hardware and software products for validating chip designs would post earnings of $1.9 per share when it actually produced earnings of $1.99, delivering a surprise of +4.74%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Cadence, which belongs to the Zacks Computer - Software industry, posted revenues of $1.47 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 1.69%. This compares to year-ago revenues of $1.24 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Cadence shares have added about 6.5% since the beginning of the year versus the S&P 500's gain of 4.7%.

What's Next for Cadence?While Cadence has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Cadence was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.92 on $1.44 billion in revenues for the coming quarter and $8.16 on $5.99 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Computer - Software is currently in the top 30% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, OptimizeRx Corp. (OPRX - Free Report) , has yet to report results for the quarter ended March 2026.

This company is expected to post quarterly earnings of $0.01 per share in its upcoming report, which represents a year-over-year change of -87.5%. The consensus EPS estimate for the quarter has been revised 23.5% lower over the last 30 days to the current level.

OptimizeRx Corp.'s revenues are expected to be $18.45 million, down 15.9% from the year-ago quarter.

April 29, 2026 16:05 ET  | Source: OptimizeRx Corporation

WALTHAM, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and Governance (ESG) report for 2026.

As a company focused on optimizing meaningful engagement opportunities at critical junctures of the healthcare journey, we remain dedicated to aligning our mission with our responsibilities as a corporate citizen.

ESG Report Highlights

The appointment of Mary Varghese Presti to our Board of Directors as an independent director furthers our ongoing process to refresh and expand our Board of Directors. Varghese Presti brings more than 25 years of experience at the intersection of healthcare, life sciences, and technology, with a track record of building and scaling platforms that translate innovation into real-world impact.We have added Scope 3 supply chain emissions to our greenhouse gas emissions reporting for the first time since beginning emissions reporting in 2022. To read our full ESG report, please visit our governance page here: https://investors.optimizerx.com/esg.

About OptimizeRx

OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.

For more information, follow the Company on X, LinkedIn or visit www.optimizerx.com. 

Important Cautions Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans, and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.

OptimizeRx Contact
Andy D’Silva, Chief Business Officer
[email protected]

Investor Relations Contact
Douglas Farrell
LifeSci Advisors, LLC
[email protected]

Wall Street expects a year-over-year decline in earnings on lower revenues when OptimizeRx Corp. (OPRX - Free Report) reports results for the quarter ended March 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 12. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.01 per share in its upcoming report, which represents a year-over-year change of -87.5%.

Revenues are expected to be $18.45 million, down 15.9% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 23.53% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for OptimizeRx?For OptimizeRx, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -500.00%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that OptimizeRx will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that OptimizeRx would post earnings of $0.23 per share when it actually produced earnings of $0.51, delivering a surprise of +121.74%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

OptimizeRx doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Expands life sciences marketers’ reach at the validated point of care, enabling DSPs to directly integrate with OptimizeRx’s trusted EHR network for the first time May 11, 2026 07:30 ET  | Source: OptimizeRx Corporation

WALTHAM, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare providers (HCPs) and patients at the most important decision points, today announced the launch of a new programmatic connection point between OptimizeRx’s proprietary EHR network and DSPs, enabling media buyers to activate scalable, point of care campaigns within their existing programmatic workflows. This launch also opens up new access for OptimizeRx to the programmatic market, estimated at 90% of the total U.S. digital display ad spend across all industries.

Bridging Point of Care Impact and Programmatic Efficiency

Life sciences media buyers have long faced a tradeoff: activate high-impact campaigns within the EHR through managed programs or buy programmatically with limited or unverified access to real clinical decision moments.

With this launch, media buyers can now combine the speed, control, and transparency of programmatic buying with the precision to reach HCPs directly in their clinical workflow.

Media buyers will be able to:

Activate EHR campaigns faster, directly through their DSPSelf-manage the reach, frequency, and scale of EHR placementsSeamlessly incorporate EHR advertising into their omnichannel strategies “The EHR is one of the most impactful places to engage HCPs, but not every life sciences brand has a practical way to access it,” said Steve Silvestro, Chief Executive Officer at OptimizeRx. “This launch changes that picture. Not only does it expand access to key clinical moments, but it also represents a step-change for DSPs seeking a competitive advantage in the life sciences market, opening the door to new demand, stronger client relationships, and higher industry revenues.”

Expanding DSP Value in the Life Sciences Market

DSPs can now integrate OptimizeRx’s EHR publisher network directly into their native platform environment, giving their life sciences clients access to premium point of care inventory within existing buying workflows.

By connecting OptimizeRx’s proprietary EHR network to their programmatic platforms, DSPs can:

Provide marketers with authenticated, bot-free EHR inventory previously unavailable at scaleDifferentiate their offerings with a high-value channel tailored to the needs of their life sciences clientsCapture an increased share of the $19B+ pharma digital ad market by meeting the demand for greater point of care access To inquire about integrating OptimizeRx into your programmatic platform, contact: Louis Trivento, SVP Strategic Partnerships, [email protected].

About OptimizeRx

OptimizeRx is a leading healthcare technology company that’s redefining how life sciences brands connect with patients and healthcare providers. Our platform combines innovative, AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood® Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.

For more information, follow the Company on LinkedIn or X, or visit www.optimizerx.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "enabling", "can", "activate", "expanding", "incorporate", "connecting" or other similar words and expressions are intended to identify these forward-looking statements. All statements in this press release that reflect the Company's expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the ability of OptimizeRx to successfully penetrate the programmatic market, a DSP’s ability to expand access to key clinical moments or gain a competitive advantage in the life sciences market, the ability of healthcare marketers to activate point of care campaigns at scale, and a DSP’s ability to better differentiate its offerings or capture greater market share by accessing the EHR network. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company’s current expectations and involve assumptions regarding the Company's business, the economy, and other future conditions that may never materialize or may prove to be incorrect. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to the effect of government regulation, seasonal trends, dependence on a concentrated group of customers, cybersecurity incidents that could disrupt operations, the ability to keep pace with growing and evolving technology, the ability to maintain contracts with eRx platforms and EHR networks, competition, and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and in other filings the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.

OptimizeRx Contact
Jennifer Dinkel, VP Marketing
[email protected]

Investor Relations Contact
Douglas Farrell
LifeSci Advisors, LLC
[email protected]

Press Inquiries
Matter Communications
[email protected]

Partnership Inquires
Louis Trivento, SVP Strategic Partnerships
[email protected]

– Q1 revenue totals $19.8 million– Q1 net loss and adjusted EBITDA came in at $(0.5) million and $3.3 million, respectively– 2026 revenue guidance updated to $95-$100 million; adjusted EBITDA guidance unchanged at $21-$25 million– Paid off an incremental $2.7 million in principal from term loan during Q1– Completed debt refinancing, subsequent to end of Q1, with a $35 million traditional banking facility, resulting in expected $1.5 million in annual interest expense savings– Launched operating efficiency initiatives, subsequent to end of Q1, with expected annualized savings of $3 million, including $1 million in 2026 WALTHAM, Mass., May 12, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced results for the three months ended March 31, 2026.

OptimizeRx Corporation (OPRX) Q1 2026 Earnings Call Transcript

Key Takeaways OPRX cut 2026 revenue outlook to $95-$100M, down from $109-$114M and earlier $118-124M.Management cites MFN pricing disruption and macro uncertainty as clients tighten budgets, delaying campaigns.OPRX's DAAP grew 60% and related subscription revenues 45%; net revenue retention stayed at 110%. OptimizeRx Corporation (OPRX - Free Report) trimmed its 2026 revenue outlook, reflecting ongoing near-term pressures. Revenues are now expected to be between $95 million and $100 million, compared with the previous range of $109-$114 million. This is the second revision to the revenue outlook, with the initial guidance of $118-$124 million provided at the end of the third quarter of 2025.

Citing disruptions stemming from the most favored nation (“MFN”) pricing dynamics and broader macroeconomic uncertainty, several clients are tightening budgets, affecting contract durations and delaying campaign timing and scope, as highlighted by the management. These factors have reduced contracted revenue visibility, prompting an outlook revision.

First-quarter revenues were down 10% year over year to $19.8 million. Management attributed this decline partly to lower managed services revenues, reduced spending from a major client account and cautious budget spend owing to the above-mentioned factors.

OPRX also noted that some of the pressure is coming from a single large client experiencing continued disruption.

Image Source: Zacks Investment Research

Despite the lowered outlook, OptimizeRx’s underlying business trends appear encouraging. The expanding adoption of OPRX’s Dynamic Audience Activation Platform is expected to support top-line growth. OPRX reported 60% growth in its DAAP platform, along with a 45% increase in related subscription revenues. Net revenue retention remained solid at 110%.

OPRX is adding more customers, especially in the mid-tier and long-tail life science companies. Management views this segment as highly attractive.

Profitability trends are also encouraging, with adjusted EBITDA full-year guidance ($21-$25 million) reiterated. Cost optimization efforts are helping offset revenue pressures. OPRX expects spending disruption to be temporary and largely confined to 2026. The company expects momentum heading into 2027. 

How Are Rivals Navigating?GoodRx Holdings, Inc. (GDRX - Free Report) is another digital healthcare company focused on medication savings in the United States and is used by nearly 25 million consumers. For 2026, the company now expects revenues of $765-$785 million, implying a decline of 1-4% from the $796.9 million reported in 2025. The earlier guided range was $750-$780 million, implying a decline of 2-6% from 2025.

Adjusted EBITDA is now expected to be at least $235 million (compared with the previous guidance of $230 million), indicating a decline from the $270.5 million reported in 2025. The increase in guidance is primarily tied to momentum in Pharma Direct and subscription revenues. Prescription transaction revenues are expected to remain under pressure in 2026.

Doximity (DOCS - Free Report) is one of the leading digital platforms for medical professionals in the United States. For fiscal 2027, revenues are expected to be between $664 million and $676 million, up roughly 4% year over year at the midpoint. Management highlighted that the broader HCP digital pharma advertising market remains soft, limiting visibility. Macro uncertainty and policy concerns are additional concerns.

Adjusted EBITDA is expected to be in the range of $323 million to $335 million, implying an adjusted EBITDA margin of approximately 49%. Fiscal 2026 adjusted EBITDA margin was 55%. The decline underscores increasing AI-related investments. 

OPRX Price Performance, Valuation & EstimatesShares of OptimizeRx have lost 22% in the past month compared with the Computer Software industry’s decline of 0.8%.

Image Source: Zacks Investment Research

Regarding the forward 12-month price/sales ratio, OPRX is trading at 0.84, lower than the sector’s multiple of 6.94.

Image Source: Zacks Investment Research

The Zacks Consensus Estimate for OPRX’s earnings for fiscal 2027 has been revised downward over the past 60 days.

Image Source: Zacks Investment Research

OPRX currently carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

OPRX's shares slid 30% in a month as MFN pricing and cautious pharma spending hit revenue, even as DAAP growth and EBITDA surged.

Key Takeaways Doximity expanded AI adoption, with 140 health systems purchasing its clinical AI suite.DOCS signed initial AI search deals with top pharma firms despite cautious ad spending trends.OptimizeRx lowered its revenue outlook as shorter contracts and client disruption hurt visibility. OptimizeRx Corporation (OPRX - Free Report) and Doximity, Inc. (DOCS - Free Report) both operate in the digital healthcare engagement space, helping pharmaceutical companies and healthcare providers improve communication, workflow efficiency and physician engagement through technology-driven platforms. The companies are also investing heavily in AI-enabled tools to expand their capabilities and strengthen their positions within healthcare marketing and clinical workflow ecosystems.

At the same time, both companies are navigating a challenging healthcare advertising environment marked by cautious pharmaceutical spending, shorter contract durations and macroeconomic uncertainty. Despite these near-term pressures, management at both firms emphasized continued customer engagement, expanding AI initiatives and long-term growth opportunities tied to digital healthcare transformation.

Let’s evaluate their fundamentals, growth prospects, market challenges and valuations to determine which one presents a stronger investment opportunity.

The Case for OPRXOptimizeRx is gaining from the continued adoption of its AI-enabled DAAP solution, which grew 60% during the first quarter. The company highlighted expanding usage from major pharmaceutical clients, where point-of-prescribe solutions have evolved from targeted engagements into scaled multi-brand deployments, driven by measurable improvements in prescriber engagement and campaign performance. Management said this demonstrates the company’s ability to deepen relationships within large enterprise accounts.

OptimizeRx is also gaining from operational improvements and strategic platform expansion initiatives. The company’s DAAP subscription revenues increased 45% year over year, helping improve revenue visibility and build a more predictable financial model. OptimizeRx also announced new integrations with demand-side platforms controlling more than 80% of digital promotional spending, which management believes could drive meaningful long-term growth and improve utilization across its EHR network.

OPRX is also benefiting from growing momentum within the medtech sector and increasing adoption among mid-tier and long-tail life sciences customers. In the last earnings call, management highlighted that initial pilot programs are expanding into multimillion-dollar engagements, reinforcing confidence in the repeatability of its growth model. Management also stated that these customer groups remain significantly underpenetrated and represent a substantial long-term opportunity.

However, OptimizeRx is facing continued macroeconomic and healthcare industry headwinds that are affecting customer spending patterns. Management stated that cautious budget allocations, shorter contract durations, delays in campaign timing related to most favored nation pricing dynamics and broader macro uncertainty are reducing visibility into full-year performance. The company lowered its full-year revenue outlook to reflect these pressures. For 2026, it expects revenues to range between $95 million and $100 million, while continuing to project adjusted EBITDA between $21 million and $25 million.

Image Source: Zacks Investment Research

OptimizeRx is also dealing with a disruption tied to one major client relationship. Management stated that execution challenges within that account, combined with organizational changes at the client, contributed to weaker contracted revenue visibility. Although management in the last earnings call stated that conversations with the client have improved and the relationship is stabilizing, the disruption is expected to continue through much of 2026.

The Case for DOCSDoximity is gaining from accelerating AI adoption and growing physician engagement across its platform. In the last earnings call, management stated that nearly half of all U.S. doctors work at hospitals using its workflow or scheduling tools, while workflow engagement reached more than 800,000 unique quarterly active prescribers, representing roughly 30% year-over-year growth. Management also stated that AI Search and Scribe users have tripled since the Pathway acquisition.

The company is benefiting from expanding adoption of its clinical AI suite among hospitals and healthcare systems. It said 140 health systems, including seven of the top 20 hospitals in the United States, have purchased its clinical AI suite, providing more than 250,000 prescribers with HIPAA-compliant AI workflows. Management highlighted strong physician preference for its AI answers in side-by-side clinical evaluations due to built-in drug references and peer-reviewed functionality.

DOCS is gaining from early traction in AI monetization opportunities. The company has already signed its first AI search agreements with the top 20 pharmaceutical manufacturers and described strong interest from pharma marketers seeking innovative AI-based engagement tools. Doximity believes AI search could represent a multibillion-dollar incremental market opportunity on top of its existing pharma advertising business.

Image Source: Zacks Investment Research

However, Doximity is grappling with softer demand conditions within the healthcare professional digital pharma advertising market. Management stated that policy uncertainty and macroeconomic concerns are leading pharmaceutical companies to make shorter-term spending commitments and maintain cautious budget strategies. The company’s visibility remains limited and it expects overall market growth to remain modest during the fiscal year.

DOCS is also experiencing margin pressure tied to elevated AI investment spending. The company noted that rising AI compute costs and increased investments in research, compute infrastructure and marketing are weighing on near-term profitability. Management expects these higher expenses to continue through fiscal 2027 as the company prioritizes long-term AI expansion initiatives.

Share Performance of OPRX & DOCSIn the past six months, OPRX stock has plunged 66% while DOCS has declined 60.3%.

Image Source: Zacks Investment Research

Valuation for OPRX & DOCSIn terms of Price/Book, OPRX shares are trading at 0.71X, lower than DOCS’ 3.94X.

Image Source: Zacks Investment Research

How Do Estimates Compare for OPRX & DOCS?Over the past 60 days, analysts have revised their estimates downward for OPRX’s bottom line for the current year.

Image Source: Zacks Investment Research

For DOCS, estimates have been revised downward over the past 60 days.

Image Source: Zacks Investment Research

OPRX or DOCS: Which Stock Is the Better Investment?While DOCS carries a Zacks Rank #3 (Hold) at present, OPRX has a Zacks Rank #4 (Sell). Consequently, in terms of Zacks Rank, DOCS seems to be a better option at the moment.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.